# CARTO-Finder Guided Ablation Versus Multiscale Entropy Guided Ablation in Persistent Atrial Fibrillation

> **NCT05454111** · NA · UNKNOWN · sponsor: **Shanghai Chest Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **PROCEDURE:** Multiscale entropy-guided ablation plus PVI
- **PROCEDURE:** CARTO-Finder-guided ablation plus PVI

## Key facts

- **NCT ID:** NCT05454111
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-07-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05454111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05454111, "CARTO-Finder Guided Ablation Versus Multiscale Entropy Guided Ablation in Persistent Atrial Fibrillation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05454111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*